TOMA Biosciences is a company providing a sequencing solution to identify changes in the DNA of cancer tumors. It offers OS-Seq cancer assay that enables analysis of tumor samples, including highly damaged samples and fine needle aspirations. The company also develops SIGNOMETM Tumor Profiling System, a solution for somatic variant detection in cancer.